Treatment of E. coli UTI at 23 Weeks Gestation
Treat immediately with oral nitrofurantoin 100 mg twice daily for 5-7 days or amoxicillin-clavulanate 500 mg three times daily for 7 days, as pregnancy makes this a complicated UTI requiring prompt antibiotic therapy to prevent maternal and fetal complications.
Why This Matters in Pregnancy
UTI in pregnancy is classified as a complicated UTI regardless of symptoms 1. This is critical because untreated bacteriuria progresses to pyelonephritis in 20-30% of pregnant women, which significantly increases risks of preterm labor, low birthweight, and maternal sepsis 2, 3. At 23 weeks gestation, you're at the threshold of viability—making infection control essential for both maternal and fetal outcomes.
First-Line Treatment Options
Preferred Agents:
Nitrofurantoin: 100 mg twice daily for 5-7 days
- Maintains 93% susceptibility against E. coli in obstetric populations 4
- Safe throughout pregnancy (avoid only at term due to theoretical hemolysis risk)
- Excellent urinary concentration with minimal resistance
Amoxicillin-clavulanate: 500 mg three times daily for 7 days 5
- High activity against top three uropathogens in pregnancy 4
- Well-established safety profile
- Broader coverage if susceptibility unknown
Alternative if Susceptibility Known:
- Cephalexin: 500 mg four times daily for 7 days 3
- Use only if organism confirmed susceptible
- First-generation cephalosporins remain reasonable options
Critical Cautions
Avoid these agents:
- Fluoroquinolones: Contraindicated in pregnancy (cartilage toxicity concerns)
- Trimethoprim-sulfamethoxazole: Avoid in second trimester if possible; associated with neural tube defects in first trimester and kernicterus risk near term 3
- Fosfomycin: While 96% effective against E. coli 4, insufficient pregnancy safety data limits recommendation despite WHO listing 6
The Resistance Problem
E. coli resistance patterns are evolving rapidly in pregnancy populations. Recent surveillance shows:
- Ampicillin resistance: 75% median globally 6—never use ampicillin alone 2, 3
- Cefuroxime susceptibility declining (95% to 81%) 4
- ESBL-producing E. coli increasing (5% to 10%) 4
This is why nitrofurantoin and amoxicillin-clavulanate remain first-line—they maintain high susceptibility rates despite widespread resistance to older agents.
Essential Follow-Up
- Obtain urine culture before starting antibiotics (if not already done)
- Repeat culture 7 days after completing therapy 5—this is mandatory in pregnancy to confirm eradication
- Monthly screening cultures for remainder of pregnancy 3
- Consider suppressive therapy if recurrent infection develops (nitrofurantoin 50-100 mg nightly)
When to Escalate Care
Hospitalize immediately if:
- Fever >38°C (suggests pyelonephritis)
- Flank pain or costovertebral angle tenderness
- Nausea/vomiting preventing oral intake
- Signs of preterm labor
- Inability to tolerate oral medications
For pyelonephritis, initiate IV ceftriaxone 1-2 g daily or IV cefotaxime 2, as oral agents are insufficient for upper tract infection.
Duration Rationale
The 7-day duration for pregnancy UTI is based on the complicated nature of infection in this population 7. While 3-day courses work for uncomplicated cystitis in non-pregnant women 1, pregnancy physiology (urinary stasis, ureteral dilation, immunologic changes) necessitates longer treatment to prevent relapse and progression to pyelonephritis.
Special Consideration at 23 Weeks
At this gestational age, you're managing not just infection but also the risk of preterm delivery. E. coli bacteriuria is associated with preterm labor through inflammatory mediator release 2. Aggressive treatment and close follow-up are non-negotiable to optimize outcomes for both mother and potentially viable fetus.